Skip to main content
2024 Guide to Patient Support Services

TerSera Therapeutics

2024 PSS Guide

TerSera SupportSource

TerSera Therapeutics offers the TerSera SupportSource program to help patients while taking a TerSera oncology medicine (Table) by removing the financial and access barriers that patients sometimes encounter.

TerSera SupportSource Co-pay Program

Eligible patients who are commercially insured may pay as little as $0 per prescription for Varubi, Zoladex, or Xermelo.

TerSera SupportSource Patient Assistance Program

This program provides Varubi or Zoladex at no cost for up to 1 year to qualifying patients. Medicine can either be sent to your office or to your patient’s home. TerSera SupportSource will help identify an appropriate patient assistance program if available for qualifying patients taking Xermelo.

TABLE TerSera Oncology/Supportive Care Drugs

Drugs
Indications
Patient support programs

Drug
Varubi (rolapitant)
Indications
Indicated in combination with other antiemetic agents for prevention of delayed nausea and vomiting in adults associated with emetogenic cancer chemotherapy, including highly emetogenic chemotherapy
Patient support programs

Drug
Xermelo (telotristat ethyl)
Indications
Treatment, in combination with a somatostatin analog, of carcinoid syndrome diarrhea in adults that is inadequately controlled by somatostatin analog therapy
Patient support programs

Drug
Zoladex (goserelin implant)
Indications
Management of localized, stage T2b-T4 (stage B2-C) prostate cancer, in combination with flutamide; palliative treatment of advanced prostate cancer; palliative treatment of advanced breast cancer in pre- and peri­menopausal women
Patient support programs